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Pharmaceutical compounds represent a rapidly emerging class of environmental contaminants. Such compounds were recently
classified by the U.S. Geological Survey, including several antibiotics. An LC-MS/MS screening method for the top five antibiotics
in drinking water was developed and validated using a Shimadzu LC-MS-IT-TOF. The separation was performed using a Waters
Acquity UPLC BEH C18 column with a gradient elution. Sulfamethazine was exposed to conditions intended to mimic drinking
water chlorination, and samples were collected and quenched with excess sodium sulfite. Kinetics of sulfamethazine degradation
was followed as well as the formation of the major chlorinated byproduct (m/z 313). For the screening method, all five antibiotic
peaks were baseline resolved within 5 minutes. Additionally, precision and accuracy of the screening method were less than 15%.
Degradation of sulfamethazine upon exposure to drinking water chlorination occurred by first order kinetics with a half-life of
5.3 × 104 min (approximately 37 days) with measurements starting 5 minutes after chlorination. Likewise, the formation of the
major chlorinated product occurred by first order kinetics with a rate constant of 2.0 × 10−2. The proposed identification of
the chlorinated product was 4-amino-(5-chloro-4,6-dimethyl-2-pyrimidinyl)-benzenesulfonamide (C12H13N4O2SCl) using MS
n
spectra and databases searches of SciFinder and ChemSpider.
1. Introduction
For over thirty years, pharmaceutical compounds have been
emerging as environmental contaminants, appearing in
drinking and waste water all over the world. The persis-
tence of pharmaceutical environmental contaminants, such
as antibiotics, in the water supply is of increasing concern
within the field of environmental toxicology. Several domes-
tic and international entities have reported the presence of
antibiotic compounds in ground water, municipal drink-
ing water, and waste water. Some of these antibiotics
include sulfonamides, fluoroquinolones, chloramphenicol,
and trimethoprim [1–6]. A recent survey of 47 groundwater
sites across 18 states conducted by the U.S. Geological Survey
found the common veterinary and human antibiotic, sulfa-
methoxazole, to be present in 23% of the samples collected
[7]. Similar results associated with high environmental levels
of sulfamethoxazole were found in a survey of the Seine
River in France [2] and the Guangzhou section of the Major
Pearl River, China [3]. While the absolute concentration of
these drugs in drinking water is certainly subclinical, their
presence has the potential to contribute to the emergence of
antibiotic-resistant bacterial strains. Bacterial strains that are
resistant to one or several commercially available antibiotic
drugs have been detected in surface, waste, and drinking
water supplies, yet the link between this phenomenon and
antibiotics in drinking water is unknown [8–11].
An added layer of complexity in this problem lies in
the potential biotransformation antibiotic compounds can
undergo during drinking water chlorination. Chlorination,
typically in the form of sodium hypochlorite, is a common
mechanism of drinking water disinfection used in the United
States. In general, drinking water sterilization byproducts
have been linked to adverse reproductive eﬀects, certain types
of cancer, and developmental problems [12]. The chemicals
used in drinking water chlorination are in high enough
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concentrations to initiate chemical reactions with low levels
of organic compounds within water, with antibiotics not
being exempt from such chemistry. Chlorination has been
shown to reduce the concentration of certain parent drugs
in drinking water [13]. The chlorination processes have also
been shown to generate chlorinated versions of ethynylestra-
diol [14] and have been associated with the formation of
multichlorinated and hydroxylated forms of trimethoprim
[15]. The eﬀect of chlorination has been studied for several
nonantibiotic drugs, including oxcarbazine [16], gemfibrozil
[17], acetaminophen [18], atenolol [19], fluoxetine [20],
and metoprolol [21]. However, these studies are few in
comparison to the variety of pharmaceutical contaminants
our environment faces.
A long-term goal of this research is to understand the
chemical fate of antibiotics in the water supply when they
are exposed to chlorination in the drinking water treatment
process and the subsequent contribution these derivatives
have to antimicrobial drug resistance. It is important to
know if the active antibiotic moiety is retained. To this end,
we have developed a screening method for accurate and
precise quantification of the top fivemost common antibiotic
contaminants in US waters, including sulfamethazine, sul-
famethoxazole, trimethoprim, lincomycin, and enrofloxacin.
Additionally, we have applied IT-TOF accurate mass capa-
bilities coupled with molecular formulae search engines
to structurally characterize the chlorinated byproduct of
sulfamethazine. No other published method currently exists
to monitor all five of these antibiotics in drinking water, nor
has anyone previously characterized the chlorination fate of
sulfamethazine.
2. Methods
2.1. Materials and Equipment. All drug standards (sulfa-
methoxazole, sulfamethazine, lincomycin, enrofloxacin, and
trimethoprim) were of analytical grade and were ac-
quired from Sigma-Aldrich (St. Louis, MO). Additionally,
the chemicals used in the chlorination experiments, sodium
hypochlorite and sodium sulfate, were of analytical grade and
also purchased from Sigma-Aldrich. The free chlorine con-
centration in the samples and stock solutions was monitored
using a Hach Pocket Colorimeter II (Loveland, CO). The
solvents used included methanol, water, and 0.1% v/v formic
acid in acetonitrile. All of these solvents were of LC-MS grade
(Burdick & Jackson, Morristown, NJ). The HPLC column
was a Waters Acquity UPLC BEH C18 column, 1.7micron,
2.1 × 100mm (Milford, MA). The Shimadzu liquid chro-
matography system consisted of two LC-20AD pumps with
UFLC-XR upgrade, SIL-20ACHT auto sampler, CTO-20A
column oven, DGU-20A3 degasser, and CBM-20A Commu-
nications module. This system was coupled to the Shimadzu
IT-TOF mass spectrometer with an electrospray (ESI) source
(Columbia, MD). The mass spectrometer utilized UHP
nitrogen as a nebulizing and drying gas and UHP argon
as a collision gas, both supplied by Airgas (Johnson City,
TN). Molecular formulae searches were performed using
the open-access ChemSpider (http://www.chemspider.com),
coordinated by the Royal Society of Chemistry in Cambridge
and SciFinder, a subscription-based service of the American
Chemical Society.
2.2. LC-MS/MS Conditions and Screening Method. The LC-
MS/MS run included a gradient elution using 80% water/
20% acetonitrile with 0.1% formic ramped to 70% organic
over 7 minutes at a flow rate of 0.200mL/min. Data was
acquired in automaticMS/MS using positive ion electrospray
(ESI) mode with a CDL and heat block temperature of
200◦C. Liquid nitrogen, used as the drying and nebulizing
gas, was kept at a flow of 1.5 L/min. Argon was used as
the collision gas for the MSn experiments. Drug solutions
(including sulfamethoxazole, sulfamethazine, lincomycin,
enrofloxacin, and trimethoprim) for the method develop-
ment and precision/accuracy experiments were prepared in
ion-free water in the following concentrations (n = 3 at each
concentration for each day): 10 µg/mL, 7.5 µg/mL, 5 µg/mL,
2.5 µg/mL, 1.0 µg/mL, 0.75 µg/mL, 0.5 µg/mL, 0.25 µg/mL,
0.1 µg/mL, and 0.05 µg/mL. These dilutions were prepared
from 1mg/mL and 100 µg/mL stock solutions in 50/50
methanol water. Following each LC-MS/MS run, the data
was collected using extracted ion chromatograms from MS1
data on the molecular ions for each drug. For calibration
purposes and assessment of method precision, the peak
areas were determined using the Shimadzu Quant Browser
software in Postrun mode. Calibration curves and replicates
at each concentration were run over three days (n = 3 at each
concentration for each day).
2.3. Kinetics Experiment. Chlorination experiments mim-
icked common water treatment practices with a chlorine
concentration of 2mg/L. Ten µg/mL sulfamethazine stan-
dards were exposed to 380 µmol/mL free absolute chlorine
(FAC) achieved by dilution of 5% sodium hypochlorite
reagent and verified using a Hach Pocket Colorimeter II.
Triplicate aliquots were prepared in amber and clear vials.
One mL samples were removed from the vials at various
time points (5min, 10min, 15min, 20min, 30min, 60min,
2 hr, 3 hr, 4 hr, 6 hr, 8 hr, 24 hr) and the progress of the
reactions halted with the addition of excess sodium sulfite:
Na2SO3 + Cl2 → 2NaCl + SO23− [22]. Upon quenching, the
samples were filtered using a 0.22micron syringe filter and
immediately analyzed using the LC-MS/MS conditions stated
above. Peak area of the sulfamethazine peak in each sample
was integrated and used to determine the reaction kinetics
of the drug degradation under these chlorinated conditions.
The other peaks in the chromatogram were explored for the
chlorine isotope pattern, and the major chlorinated product
(m/z 313) was chosen for additional monitoring.
2.4. MSn Experiment. The major chlorinated product from
sulfamethazine’s reaction with sodium hypochlorite, m/z
313, was subjected to MS5 in order to propose a structure for
this derivative; however, no further fragmentation was noted
after MS4. Initially, a full scan MS1 spectrum was used to
identify relevant fragments, and subsequent MSn fragmen-
tations were proposed in the following manner: MS/MS of
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Figure 1: Chromatogram from antibiotic screening method, con-
centration of each compound = 5 µg/mL.
m/z 313; MS3 of m/z 313,279; MS4 and MS5 of m/z 313,
279, 186. Prior to MSn experiments, the instrument was
calibrated with sodium trifluoroacetic acid in acetonitrile,
as recommended by the manufacturer. At each MSn level,
the formula predictor software was used to generate possible
formulae for the fragments, and knowing the fragmentation
pattern for the parent drug, a proposed structure was gen-
erated from the MSn pattern. The molecular formula of
this derivative was searched on ChemSpider and SciFinder,
and a match, which posed significant similarity to the pa-
rent sulfamethazine structure, was generated. The MSn ex-
periment was repeated over three diﬀerent days, following
instrument calibration each day, to ensure that a consistent
fragmentation pattern and subsequent derivative structure
was generated.
3. Results and Discussion
3.1. Screening Method Precision and Accuracy. All five antibi-
otic peaks were well resolved within 5 minutes, as shown
in Figure 1 where each compound is represented by a 5 µg/
mL concentration. Additionally, precision (represented by
% relative standard deviation) and accuracy (represented
by % error) is acceptable (<15%) for each drug. Due to
variable sensitivities, the limits of detection (as defined as
3 : 1 signal to noise ratio) were diﬀerent for each com-
pound, ranging from 0.1 µg/mL for trimethoprim to 1 µg/mL
for sulfamethazine and sulfamethoxazole. These data are
summarized in Table 1. The repeatability and accuracy of
this assay conferred confidence that it would be useful for
monitoring drug degradation under chlorinated conditions.
The calibration slopes were also reproducible, with % RSD
ranging from 3.1–11.5% over three days (data not shown).
Although increased sensitivity could have been achieved by
conducting direct MS/MS experiments on the relevant m/z
for each drug, the full scan nature of this assay is preferred
because it does not exclude additional peaks that are likely to
appear as a result of chlorination treatment. Trimethoprim
and sulfamethoxazole have already been monitored to some
degree following chlorination treatment [15, 21]; however,
they were included in the screening assay because they are
in the top five antibiotic contaminants in the USGS survey
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Figure 2: Postchlorination chromatogram, sulfamethazine (10
minute reaction time), showing major chlorination product (m/z
313).
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Figure 3: Formation of major sulfamethazine product following
chlorination treatment over 8 hours.
[6, 7]. Because all of the top five antibiotic contaminants are
included in this assay, themethod can be used formonitoring
any of these individually as well as any combination thereof.
3.2. Kinetics of Sulfamethazine Degradation. The kinetics of
sulfamethazine chlorination was followed as well as the
formation of the major chlorinated byproduct (m/z 313).
This post-chlorination of sulfamethazine, following a 10
minute reaction with NaClO, is shown in Figure 2. Themajor
chlorinated product, which was identified as chlorinated by
the mass spectral isotope pattern on the molecular ion, elutes
at 4.5 minutes. Degradation of sulfamethazine upon expo-
sure to drinking water chlorination occurred by first order
kinetics with a half-life of 5.3 × 104 min (approximately
37 days) with measurements starting 5 minutes after chlo-
rination. Likewise, the formation of the major chlorinated
product occurred by first order kinetics with a rate constant
of 2.0 × 10−2. These data are shown in Figure 3, out to a
reaction time of 480 minutes. Data after 8 hr did not demon-
strate significant additional sulfamethazine degradation, as
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Figure 5: MS/MS and MS3 spectra of chlorinated sulfamethazine derivative with structure and proposed fragmentation pattern.
demonstrated by their lack of statistically significant diﬀer-
ence from the 480 minute time point. Consequently, to show
the detail of the reaction approaching steady state, the data
are only shown through the first 8 hours. The data shown
are from the amber-vial experiments; we saw no significant
diﬀerence in kinetics between these conditions versus the
clear vials, indicating minimal to no contribution of UV light
to the reaction progression during the time monitored.
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Table 1: LC-MS precision, accuracy, calibration ranges, and limits of detection for each compound encompassed in the screening method
(n = 3 for each concentration for each day for each drug).
Drug
Calibration Interday precision Inter-day accuracy Limit of detection
Range (µg/mL) (% RSD) Range (% error) Range (LOD)
Lincomycin (406.5 g/mol) 10–0.75 3.7–13.3% 0.30–14.8% 0.5 µg/mL
Trimethoprim (290.3 g/mol) 10–0.5 3.8–6.3% 0.40–14.8% 0.1 µg/mL
Enrofloxacin (359.4 g/mol) 10–1.0 3.9–13.8% 1.2–14.6% 0.75 µg/mL
Sulfamethazine (278.3 g/mol) 10–2.5 4.2–12.6% 0.95–12.7% 1 µg/mL
Sulfamethoxazole (253.3 g/mol) 10–2.5 2.1–7.2% 0.23–14.7% 1 µg/mL
3.3. MSn of Major Product. The MS/MS and MS3 spectra
for sulfamethazine are shown in Figure 4. The similarities
between these spectra and that of the derivative are striking
(Figure 5), especially the major fragment in MS3 of m/z 186.
Additionally, theMS4 spectrum for the chlorinated derivative
shows a weak m/z 124, which appears in the MS2 spectrum
of sulfamethazine. Finally, the MS/MS spectrum of the
derivative shows an m/z 279 fragment, which corresponds
to the loss of chlorine from the parent molecule and also
matched the m/z of the parent, indicating the addition of
only one chlorine atom upon hypochlorite exposure to the
parent. The one chlorine addition to the parent is confirmed
in the isotope pattern of the m/z 313 peak, which shows a
one-third sizem/z 315 fragment. This characteristic chlorine
isotope pattern is not seen in any of the fragment spectra
from the derivative, confirming that loss of chlorine is the
first process to occur upon fragmentation. Based on MSn
data, molecular formulae generated by the Formula Predictor
software (Shimadzu), and results from the SciFinder and
ChemSpider databases, the proposed identification of the
chlorinated product is 4-amino-(5-chloro-4,6-dimethyl-2-
pyrimidinyl)-benzenesulfonamide (C12H13N4O2SCl). This
compound was previously synthesized by Drake et al. by
coupling N-acetylsulfanilyl chloride to the amine in pyridine
followed by hydrolysis with sodium hydroxide [23]. This
reaction involved a 2-hour incubation time at 60–70◦C
temperatures to achieve a 47% yield. Based on the relative
peak areas, our yields range from 8.8–7.1% over a 24-hour
reaction time.
4. Conclusions
This method demonstrates an accurate and precise way to
screen for the top five antibiotic contaminants in drinking
water as identified by the USGS. Being able to track the
fate of these compounds in drinking water, especially fol-
lowing chemical treatment, allows for approximation of drug
half-life in these conditions, helping us understand their per-
sistence in the environment. Furthermore, the use of hyb-
rid ion-trap time-of-flight mass spectrometry enables high
mass accuracy MSn experiments to be conducted on the
chlorinated antibiotic derivatives in conjunction with quan-
titative determination of the parent compounds. Historically,
drinking water chlorination has been shown to produce
derivatives of other organic compounds, termed chlorination
byproducts, and these experiments demonstrate that sul-
fonamide antibiotics are no exception to this phenomenon.
Currently, the persistence of the 4-amino-(5-chloro-4,6-
dimethyl-2-pyrimidinyl)-benzenesulfonamide in drinking
water is unknown, but if it follows the trend of other envi-
ronmental halogenated organics, the persistence is possibly
quite high. This has implications for the contribution that
these chlorinated antibiotics in the environment may have
toward promoting bacterial resistance. Finally, this work
demonstrates that the chlorinated derivative of sulfamet-
hazine can be synthesized, albeit with much lower yields,
under conditions much simpler than previously reported.
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